{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:01:52Z","timestamp":1792785712610,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Research Funding for University","award":["57722172107"],"award-info":[{"award-number":["57722172107"]}]},{"name":"Ministry of Health (Directorate General for Animal Health and Veterinary Medicines)","award":["02769.N.VLY"],"award-info":[{"award-number":["02769.N.VLY"]}],"id":[{"id":"https:\/\/ror.org\/055546q82","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ejmech.2018.09.048","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T12:31:16Z","timestamp":1537187476000},"page":"937-950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines"],"prefix":"10.1016","volume":"158","author":[{"given":"Valeria","family":"Sorrenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1856-0308","authenticated-orcid":false,"given":"Valeria","family":"Pittal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-3479","authenticated-orcid":false,"given":"Emanuele","family":"Amata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dichiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Marrazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5895-7820","authenticated-orcid":false,"given":"Rita","family":"Turnaturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Prezzavento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"Barbagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Vanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5039-2151","authenticated-orcid":false,"given":"Antonio","family":"Rescifina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0668-1260","authenticated-orcid":false,"given":"Giuseppe","family":"Floresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Tibullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Intagliata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.09.048_bib1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1073\/pnas.61.2.748","article-title":"The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase","volume":"61","author":"Tenhunen","year":"1968","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2018.09.048_bib2","first-page":"797","article-title":"The heme oxygenase system: past, present, and future","volume":"6","author":"Maines","year":"2004","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2018.09.048_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0162-0134(00)00156-2","article-title":"Mechanism of heme degradation by heme oxygenase","volume":"82","author":"Yoshida","year":"2000","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib4","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2174\/1381612823666170210151411","article-title":"Novel caffeic acid phenethyl ester (Cape) analogues as inducers of heme oxygenase-1","volume":"23","author":"Pittal\u00e0","year":"2017","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2018.09.048_bib5","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2174\/0929867324666170616110748","article-title":"Effects of polyphenolic derivatives on heme oxygenase-system in metabolic dysfunctions","volume":"25","author":"Pittal\u00e0","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1152\/physrev.00011.2005","article-title":"Heme oxygenase-1\/carbon monoxide: from basic science to therapeutic applications","volume":"86","author":"Ryter","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2018.09.048_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/CS20110147","article-title":"Haem oxygenase-1: non-canonical roles in physiology and pathology","volume":"122","author":"Grochot-Przeczek","year":"2012","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejmech.2018.09.048_bib8","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1042\/CS20170157","article-title":"Role of the Nrf2\/HO-1 axis in bronchopulmonary dysplasia and hyperoxic lung injuries","volume":"131","author":"Amata","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejmech.2018.09.048_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/antiox6020029","article-title":"HO-1 Induction in Cancer Progression: a matter of cell adaptation","volume":"6","author":"Nitti","year":"2017","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2018.09.048_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12929-015-0128-0","article-title":"Heme oxygenase-1: emerging target of cancer therapy","volume":"22","author":"Chau","year":"2015","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.ejmech.2018.09.048_bib11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/156800909789057024","article-title":"Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy","volume":"9","author":"Gleixner","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejmech.2018.09.048_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/ars.2016.6735","article-title":"The heme oxygenase system in hematological malignancies","volume":"27","author":"Li Volti","year":"2017","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2018.09.048_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejmech.2017.07.031","article-title":"Heme oxygenase-1: a new druggable target in the management of chronic and acute myeloid leukemia","volume":"142","author":"Salerno","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Melo","year":"2007","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2018.09.048_bib15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.leukres.2010.04.016","article-title":"BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review","volume":"34","author":"An","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejmech.2018.09.048_bib16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O'Brien","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.09.048_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.canlet.2006.07.010","article-title":"Resistance to imatinib mesylate in chronic myeloid leukaemia","volume":"249","author":"Melo","year":"2007","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2018.09.048_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.leukres.2017.01.005","article-title":"Current approach to the treatment of chronic myeloid leukaemia","volume":"55","author":"Pasic","year":"2017","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejmech.2018.09.048_bib19","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1073\/pnas.162140299","article-title":"Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop","volume":"99","author":"Roumiantsev","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2018.09.048_bib20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.09.048_bib21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/ars.2011.4258","article-title":"Redox control of leukemia: from molecular mechanisms to therapeutic opportunities","volume":"18","author":"Irwin","year":"2013","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2018.09.048_bib22","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1158\/0008-5472.CAN-03-1200","article-title":"Identification of heme oxygenase-1 as a novel BCR\/ABL-dependent survival factor in chronic myeloid leukemia","volume":"64","author":"Mayerhofer","year":"2004","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.09.048_bib23","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.2174\/1381612811319150012","article-title":"Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells","volume":"19","author":"Tibullo","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2018.09.048_bib24","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.bmc.2013.06.040","article-title":"Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties","volume":"21","author":"Salerno","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vph.2015.09.004","article-title":"HO-1\/CO system in tumor growth, angiogenesis and metabolism - targeting HO-1 as an anti-tumor therapy","volume":"74","author":"Loboda","year":"2015","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.09.048_bib26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejmech.2015.04.003","article-title":"Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines","volume":"96","author":"Salerno","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejmech.2017.05.016","article-title":"Designing multi-targeted agents: an emerging anticancer drug discovery paradigm","volume":"136","author":"Fu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/cbdd.12015","article-title":"Evaluation of imidazole-based compounds as heme oxygenase-1 inhibitors","volume":"80","author":"Sorrenti","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2018.09.048_bib29","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.2174\/0929867311320300003","article-title":"A\u00a0focus on heme oxygenase-1 (HO-1) inhibitors","volume":"20","author":"Pittal\u00e0","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib30","doi-asserted-by":"crossref","first-page":"20120697","DOI":"10.1098\/rsif.2012.0697","article-title":"Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds","volume":"10","author":"Rahman","year":"2013","journal-title":"J.\u00a0R. Soc. Interface"},{"key":"10.1016\/j.ejmech.2018.09.048_bib31","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/cmdc.201700321","article-title":"Heme oxygenase database (HemeOxDB) and QSAR analysis of isoform 1 inhibitors","volume":"12","author":"Amata","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.09.048_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.dib.2017.09.036","article-title":"Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors","volume":"15","author":"Amata","year":"2017","journal-title":"Data in brief"},{"key":"10.1016\/j.ejmech.2018.09.048_bib33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1389557517666170228113656","article-title":"Imidazole: an essential edifice for the identification of new lead compounds and drug development","volume":"18","author":"Shalmali","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib34","doi-asserted-by":"crossref","first-page":"7702","DOI":"10.1021\/jm5009314","article-title":"Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation","volume":"57","author":"Ferla","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1021\/jm401546n","article-title":"Discovery of 1-methyl-1H-imidazole derivatives as potent Jak2 inhibitors","volume":"57","author":"Su","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1124\/jpet.110.168492","article-title":"The effects of azole-based heme oxygenase inhibitors on rat cytochromes P450 2E1 and 3A1\/2 and human cytochromes P450 3A4 and 2D6","volume":"334","author":"Hum","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2018.09.048_bib37","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1873-3468.12057","article-title":"Secretion of IL-1\u03b2 from imatinib-resistant chronic myeloid leukemia cells contributes to BCR-ABL mutation independent imatinib resistance","volume":"590","author":"Lee","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2018.09.048_bib38","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3324\/haematol.12186","article-title":"Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients treated with nilotinib","volume":"93","author":"La Rosee","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.ejmech.2018.09.048_bib39","doi-asserted-by":"crossref","first-page":"36842","DOI":"10.1074\/jbc.M110.170324","article-title":"CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1","volume":"285","author":"Datta","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/abbi.2000.1921","article-title":"Induction of the heme oxygenase-1 gene by metalloporphyrins","volume":"380","author":"Shan","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2018.09.048_bib41","first-page":"4236","article-title":"Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)","volume":"62","author":"Nagar","year":"2002","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.09.048_bib42","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejmech.2018.02.007","article-title":"Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors","volume":"148","author":"Salerno","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib44","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/molecules23051209","article-title":"Novel structural insight into inhibitors of heme oxygenase-1 (HO-1) by new imidazole-based compounds: biochemical and in\u00a0vitro anticancer activity evaluation","volume":"23","author":"Greish","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.09.048_bib45","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/cmdc.201800176","article-title":"Identification of potentially potent heme oxygenase 1 inhibitors through 3D-QSAR coupled to scaffold-hopping analysis","volume":"13","author":"Floresta","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.09.048_bib46","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1073\/pnas.1214330110","article-title":"Explaining why Gleevec is a specific and potent inhibitor of Abl kinase","volume":"110","author":"Lin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2018.09.048_bib47","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bmc.2013.10.040","article-title":"Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level","volume":"22","author":"Peng","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib48","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/cbdd.12272","article-title":"Design, synthesis and biological evaluation of pyridin-3-yl pyrimidines as potent Bcr-Abl inhibitors","volume":"83","author":"Pan","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2018.09.048_bib49","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2018.09.048_bib50","article-title":"Heme oxygenase inhibition sensitizes neuroblastoma cells to carfilzomib","author":"Barbagallo","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2018.09.048_bib51","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/cmdc.201100602","article-title":"Heme oxygenase inhibition by alpha-(1H-imidazol-1-yl)-omega-phenylalkanes: effect of introduction of heteroatoms in the alkyl linker","volume":"7","author":"Vlahakis","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.09.048_bib52","first-page":"31","article-title":"Antiproliferative effect of oleuropein in prostate cell lines","volume":"41","author":"Acquaviva","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejmech.2018.09.048_bib53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.csbj.2016.12.002","article-title":"Chagas disease research and development: is there light at the end of the tunnel?","volume":"15","author":"Chatelain","year":"2017","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2018.09.048_bib54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00894-004-0183-z","article-title":"Optimization of parameters for semiempirical methods IV: extension of MNDO, AM1, and PM3 to more main group elements","volume":"10","author":"Stewart","year":"2004","journal-title":"J.\u00a0Mol. Model."},{"key":"10.1016\/j.ejmech.2018.09.048_bib55","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/jcc.540140706","article-title":"Suitability of the Mp3-derived molecular electrostatic potentials","volume":"14","author":"Aleman","year":"1993","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib56","series-title":"MOPAC2016 Stewart Computational Chemistry","year":"2016"},{"key":"10.1016\/j.ejmech.2018.09.048_bib57","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/jcc.10349","article-title":"A\u00a0point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations","volume":"24","author":"Duan","year":"2003","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib58","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/bioinformatics\/btu426","article-title":"YASARA View - molecular graphics for all devices - from smartphones to workstations","volume":"30","author":"Krieger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2018.09.048_bib59","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jcc.23899","article-title":"New ways to boost molecular dynamics simulations","volume":"36","author":"Krieger","year":"2015","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0065-3233(03)66002-X","article-title":"Force fields for protein simulations","volume":"66","author":"Ponder","year":"2003","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.ejmech.2018.09.048_bib61","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple Amber force fields and development of improved protein backbone parameters","volume":"65","author":"Hornak","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2018.09.048_bib62","series-title":"Designing Drugs and Crop Protectants: Processes, Problems and Solutions","article-title":"The Pre ADME Approach: web-based program for rapid prediction of physico-chemical, drug absorption and drug-like properties","author":"Lee","year":"2003"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418308201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418308201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:49:22Z","timestamp":1759326562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418308201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":62,"alternative-id":["S0223523418308201"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.048","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}